Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Amir Hamdi"'
Autor:
Babak Bahar, Masoud Iravani, Seyyed-Asadollah Mousavi, Eisa Baybordi, Mohammad Jahani, Leila Sharifi-Aliabadi, Arash Jalali, Amir Hamdi, Fatemeh Ghaffari, Ardeshir Ghavamzadeh, Kamran Alimoghaddam
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 6, Iss 3, Pp 6-11 (2012)
Introduction: Despite high remission rates in acute lymphoblastic leukemia (ALL) patients after induction chemotherapies, post- remission therapies needed to avoiding relapse. Autologous hematopoietic stem cell transplantation (HSCT) role in the trea
Externí odkaz:
https://doaj.org/article/86855f302b214bebb0815d015b52ea12
Autor:
Arash Jalali, Fatemeh Ghaffari, Amir Hamdi, Babak Bahar, Masoud Iravani, Seyyedasadollah Mousavi, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Mohammad Jahani
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 5, Iss 4, Pp 1-4 (2011)
Post-remission treatment in patients with acute myeloid leukemia is still controversial. One potent choice for patients with no donor available is autologous stem cell transplantation. The median follow-up period was 18 months and the median age was
Externí odkaz:
https://doaj.org/article/980fcbfc203942dd83300f6433c9f35b
Autor:
Masoud Iravani, Seyyed Asadollah Mousavi, Babak Bahar, Mohammad Jahani, Amir Hamdi, Amir Ali Hamidieh, Kamran Alimoghaddam, Mahdi Jalili, Arash Jalali, Ardeshir Ghavamzadeh
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 5, Iss 4, Pp 22-27 (2011)
Introduction: Severe acquired aplastic anemia (SAA) is a rare disease and matched related hematopoietic stem cell transplantation (HSCT) is the treatment of choice especially in pediatric patients. Immunosuppressive therapy is the alternative treatme
Externí odkaz:
https://doaj.org/article/b78d0a91b2ce41a7b9a035431ff4a257
Autor:
Fatemeh Ghaffari, Amir Hamdi, Arash Jalali, Leila Sharifi-Aliabadi, Mohammad Jahani, Eisa Baybordi, Seyyed-Asadollah Mousavi, Masoud Iravani, Babak Bahar, Ardeshir Ghavamzadeh, Kamran Alimoghaddam
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 6, Iss 3 (2012)
Introduction: Despite high remission rates in acute lymphoblastic leukemia (ALL) patients after induction chemotherapies, post- remission therapies needed to avoiding relapse. Autologous hematopoietic stem cell transplantation (HSCT) role in the trea
Externí odkaz:
https://doaj.org/article/6387fa707bcb4039a366eba640c35319
Autor:
Mahdi Jalili, Kamran Alimoghaddam, Amir Ali Hamidieh, Amir Hamdi, Mohammad Jahani, Babak Bahar, Seyyed Asadollah Mousavi, Masoud Iravani, Arash Jalali, Ardeshir Ghavamzadeh
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 5, Iss 4 (2011)
Introduction: Severe acquired aplastic anemia (SAA) is a rare disease and matched related hematopoietic stem cell transplantation (HSCT) is the treatment of choice especially in pediatric patients. Immunosuppressive therapy is the alternative treatme
Externí odkaz:
https://doaj.org/article/72fcdd27aa8a4371a749c62ac576119a
Autor:
Ardeshir Ghavamzadeh, Kamran Alimoghaddam, Seyyedasadollah Mousavi, Babak Bahar, Masoud Iravani, Amir Hamdi, Fatemeh Ghaffari, Arash Jalali, Mohammad Jahani
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 5, Iss 4 (2011)
Post-remission treatment in patients with acute myeloid leukemia is still controversial. One potent choice for patients with no donor available is autologous stem cell transplantation. The median follow-up period was 18 months and the median age was
Externí odkaz:
https://doaj.org/article/4dcd8f52235647c28f4acb2c64815db7
Autor:
Amir Hamdi, Chitra Hosing, Medhavi Honhar, Uday R. Popat, Richard E. Champlin, Donna M. Weber, Gabriela Rondon, Muzaffar H. Qazilbash, Rima M. Saliba, Sheeba K. Thomas, Robert Z. Orlowski, Qaiser Bashir, A. Megan Cornelison, Aimaz Afrough, Ankur Varma, Nina Shah, Simrit Parmar
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:2197-2203
With the availability of immunomodulatory imide drugs (IMiDs) and proteasome inhibitors (PI), most patients with immunoglobulin light chain amyloidosis (AL) receive induction therapy before autologous hematopoietic stem cell transplantation (auto-HCT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::143fd5bff2261d45bd42f61d00915cf6
https://doi.org/10.1016/j.bbmt.2018.07.010
https://doi.org/10.1016/j.bbmt.2018.07.010
Publikováno v:
Journal of Critical Care. 35:84-89
The purpose was to investigate the association between acid-base disturbances and mortality in acute poisoning.We performed a retrospective cross-sectional exploratory study on all acutely poisoned patients older than 12 years who had been admitted t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc8d15b92e2c9edca49c1e2e85c2d00e
https://doi.org/10.1016/j.jcrc.2016.05.003
https://doi.org/10.1016/j.jcrc.2016.05.003
Autor:
Jeffrey J. Tarrand, Borje S. Andersson, Richard J. Jones, Roy F. Chemaly, Amanda Olson, Amir Hamdi, Ala Abudayyeh, Gabriella Rondon, Wolfgang C. Winkelmayer, Charles Martinez, Aimaz Afrough, Dimitrios P. Kontoyiannis, Richard E. Champlin, Abdulla K. Salahudeen, David Marin, Katy Rezvani, Uday R. Popat, A O Gaber, Huei K. Lin, Elizabeth J. Shpall, Maen Abdelrahim, Betul Oran
Publikováno v:
American Journal of Transplantation. 16:1492-1502
Nephropathy due to BK virus (BKV) infection is an evolving challenge in patients undergoing hematopoietic stem cell transplantation (HSCT). We hypothesized that BKV infection was a marker of kidney function decline and a poor prognostic factor in HSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22a7748ee571342832ffdeeb278139db
https://doi.org/10.1111/ajt.13635
https://doi.org/10.1111/ajt.13635
Autor:
Amin M. Alousi, Amir Hamdi, Partow Kebriaei, Uday R. Popat, Aimaz Afrough, Muzaffar H. Qazilbash, Betul Oran, Roy F. Chemaly, Elizabeth J. Shpall, Lohith Gowda, Gabriela Rondon, Denái R. Milton, Armin Ghobadi, Richard E. Champlin, Stefan O. Ciurea, Qaiser Bashir
Publikováno v:
Curr Res Transl Med
HLA-DP mismatched allogeneic hematopoietic stem cell transplantation (allo-HCT) is associated with increased risk of aGVHD and decreased risk of relapse with no effects on overall survival (OS). It has been proposed that CMV-reactivation induces expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91bd345cba0739022f7e14e5ae52f186
https://pubmed.ncbi.nlm.nih.gov/30683577
https://pubmed.ncbi.nlm.nih.gov/30683577